Status:
UNKNOWN
Hepatocyte Matrix Implant Study
Lead Sponsor:
Baermed
Conditions:
Liver Disease
Liver Cirrhosis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This clinical investigation of the hepatocyte matrix implant is an evaluation blinded non-randomized and monocentric pilot study of Phase I, which is conducted as a therapeutic investigation. Randomiz...
Eligibility Criteria
Inclusion
- Main
- endstage liver disease
- stable and non-improving liver condition for at least 3 month
- alcoholic liver cirrhosis: proven alcohol abstinence for 6 month or more
- patient in bad general condition
- Main
Exclusion
- pregnancy
- drug addiction (except alcohol)
- psychiatric disease
- HIV positive
- sepsis
- peritoneal carcinosis
- hereditary liver disease
- acute liver failure
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00935454
Start Date
July 1 2009
End Date
March 1 2012
Last Update
April 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baermed Center For Abdominal Surgery
Zurich, Canton of Zurich, Switzerland, 8032